Insufficient scRNA-seq data for expression of ASB9 at single-cell level.
Insufficient scRNA-seq data for expression of ASB9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 534.39 | 89 / 89 | 91% | 7.51 | 822 / 901 |
thymus | 97% | 109.40 | 631 / 653 | 94% | 5.69 | 566 / 605 |
pancreas | 99% | 228.26 | 326 / 328 | 88% | 10.85 | 156 / 178 |
liver | 99% | 371.16 | 224 / 226 | 87% | 10.35 | 353 / 406 |
skin | 89% | 68.42 | 1611 / 1809 | 95% | 26.37 | 449 / 472 |
lung | 99% | 194.77 | 572 / 578 | 82% | 7.15 | 946 / 1155 |
intestine | 91% | 76.63 | 875 / 966 | 87% | 10.89 | 456 / 527 |
stomach | 97% | 179.49 | 347 / 359 | 75% | 8.09 | 215 / 286 |
breast | 99% | 126.07 | 455 / 459 | 58% | 3.18 | 651 / 1118 |
bladder | 95% | 67.90 | 20 / 21 | 59% | 5.64 | 298 / 504 |
uterus | 99% | 106.91 | 169 / 170 | 51% | 3.99 | 236 / 459 |
esophagus | 94% | 67.42 | 1365 / 1445 | 56% | 3.95 | 103 / 183 |
prostate | 96% | 72.97 | 234 / 245 | 44% | 3.47 | 220 / 502 |
ovary | 61% | 28.81 | 109 / 180 | 59% | 3.42 | 252 / 430 |
adrenal gland | 96% | 72.52 | 247 / 258 | 18% | 0.97 | 42 / 230 |
spleen | 100% | 769.27 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 146.01 | 1190 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 17.28 | 77 / 80 |
heart | 85% | 67.46 | 731 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 47.81 | 980 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 4.36 | 26 / 45 |
brain | 24% | 8.93 | 647 / 2642 | 17% | 0.61 | 120 / 705 |
muscle | 26% | 18.50 | 211 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 15% | 12.33 | 142 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.16 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | ASB9 |
Protein name | Ankyrin repeat and SOCS box protein 9 (ASB-9) Ankyrin repeat and SOCS box-containing 9 Ankyrin repeat and SOCS box-containing 9, isoform CRA_a (Testis tissue sperm-binding protein Li 57p) Ankyrin repeat and SOCS box containing 9 |
Synonyms | hCG_15754 |
Description | FUNCTION: Substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes at least two forms of creatine kinase, CKB and CKMT1A. . |
Accessions | Q96DX5 ENST00000546332.1 [Q96DX5-2] A0A024RBW7 ENST00000477346.6 ENST00000380488.9 [Q96DX5-1] R4GN94 ENST00000380483.7 [Q96DX5-3] Q7Z4A2 ENST00000380485.7 [Q96DX5-2] |